Skip to main content
. 2016 May 23;34(20):2333–2340. doi: 10.1200/JCO.2015.64.8899

Fig 1.

Fig 1.

CONSORT diagram for the DASISION trial after a minimum follow-up of 5 years. CML-CP, chronic myeloid leukemia in chronic phase; Ph+, Philadelphia chromosome positive. (*) Reasons for discontinuation are listed in Table 1.